LAURA WOLSKO, MD
Endocrinology, Diabetes & Metabolism Physician in LAFAYETTE, Colorado. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
LAURA WOLSKO, MD filed 868 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in LAFAYETTE, Colorado, prescribing 76% generic.
- 868
- Part D claims, 2023
- 76%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
LAURA WOLSKO, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
868 Top 27% higher than 73% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
LAURA WOLSKO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about LAURA WOLSKO, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Colorado
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Colorado providers
Endocrinology, Diabetes & Metabolism Physician share within Colorado
Endocrinology, Diabetes & Metabolism Physician is one of the more visible NUCC categories in Colorado
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
Specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
LAURA WOLSKO, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 280 EXEMPLA CIR, LAFAYETTE, CO, 80026, with a listed phone of (303) 338-4545. NPI 1538166707 was issued on 07/03/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WOLSKO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 868 prescription claims written by this provider, covering 185 Medicare beneficiaries and totaling roughly $284K in drug spend, split 24% brand-name and 76% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1538166707 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/03/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm LAURA WOLSKO, MD's current license status, disciplinary history, and board certifications with the Colorado Medical Board in Colorado before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where LAURA WOLSKO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
24% brand-name claims vs 76% generic, on 868 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,947
- Total Day Supply
- 57,208
- Brand vs Generic
- 24% brand / 76% generic
- Brand Drug Cost
- $266K
- Generic Drug Cost
- $17K
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 1.46
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 15, 65-74: 92, 75-84: 59, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What LAURA WOLSKO, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
215 claims
- Forteo
Forteo
129 claims
- Methimazole 74
Methimazole
74 claims
- Alendronate Sodium 51
Alendronate Sodium
51 claims
- Prednisone 44
Prednisone
44 claims
- Testosterone 39
Testosterone
39 claims
- Humalog 32
Humalog
32 claims
- Calcitriol 30
Calcitriol
30 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 215 |
| Forteo Teriparatide | 129 |
| Methimazole | 74 |
| Alendronate Sodium | 51 |
| Prednisone | 44 |
| Testosterone | 39 |
| Humalog Insulin Lispro | 32 |
| Calcitriol | 30 |
| Hydrocortisone | 16 |
| Dexamethasone Sodium Phosphate | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How LAURA WOLSKO, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
LAURA WOLSKO, MD's 868 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Colorado
Other clinicians with the same primary specialty enrolled in Colorado, drawn from the same CMS NPPES roster as WOLSKO.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Colorado
Frequently Asked Questions
What is LAURA WOLSKO, MD's specialty? ▼
How much does LAURA WOLSKO, MD prescribe under Medicare Part D? ▼
Where is LAURA WOLSKO, MD located? ▼
What is LAURA WOLSKO, MD's NPI number? ▼
Does LAURA WOLSKO, MD prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does LAURA WOLSKO, MD prescribe most often? ▼
Does LAURA WOLSKO, MD accept Medicare? ▼
How can I verify LAURA WOLSKO, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology